Oncology Institute Inc. (TOI)
1.10
-0.11 (-9.09%)
At close: Mar 27, 2025, 3:59 PM
-9.09% (1D)
| Bid | 1.01 |
| Market Cap | 83.12M |
| Revenue (ttm) | 392.91M |
| Net Income (ttm) | -60.97M |
| EPS (ttm) | -0.71 |
| PE Ratio (ttm) | -1.55 |
| Forward PE | -5.22 |
| Analyst | Buy |
| Ask | 1.35 |
| Volume | 847,623 |
| Avg. Volume (20D) | 781,515 |
| Open | 1.21 |
| Previous Close | 1.21 |
| Day's Range | 1.01 - 1.34 |
| 52-Week Range | 0.13 - 1.78 |
| Beta | 0.43 |
About TOI
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants ser...
Industry Medical - Care Facilities
Sector Healthcare
IPO Date Jun 4, 2020
Employees 700
Stock Exchange NASDAQ
Ticker Symbol TOI
Website https://theoncologyinstitute.com
Analyst Forecast
According to 1 analyst ratings, the average rating for TOI stock is "Buy." The 12-month stock price forecast is $2.5, which is an increase of 127.27% from the latest price.
Stock Forecasts3 days ago
+24.47%
The Oncology Institute shares are trading higher f...
Unlock content with
Pro Subscription
4 months ago
-23.47%
The Oncology Institute shares are trading lower. The stock may be moving on continued weakness following worse-than-expected Q3 financial results reported on Wednesday.
